Marinomed Biotech AG

Major Shareholding Notification • Feb 14, 2023

Publication: 14.02.2023 14:00 Source: https://www.pressetext.com/news/20230214035 Keywords: Unternehmen / Beteiligungsmeldung / Marinomed Biotech AG

Holding announcement according to article 135 section 2 BörseG (ESMA 2015/1597)

Marinomed Biotech AG: Release according to article 135 section 2 BörseG

Korneuburg (pta/14.02.2023/14:00) - Release of Announcement according to article 135 section 2 BörseG

Notification of Major Holdings

1. Issuer

Marinomed Biotech AG, Hovengasse 25, 2100 Korneuburg, Austria

2. Reason for notification

Acquisition / disposal of shares with voting rights

3. Details of person subject to the notification obligation

Name: LLB Invest Kapitalanlagegesellschaft m.b.H. City and country of registered office: Vienna, Austria

4. Names of shareholders, if different from declarants (3)

5. Date on which threshold was crossed or reached 13.02.2023

6. Total positions

	% of voting rights attached to shares (total of 7.a.)	% of voting rights through instruments (total of 7.b.1 + 7.b.2)	total of both in % (7.a. + 7.b.)	total number of voting rights of issuer
Resulting situation on the date on which threshold was crossed / reached	4,01	0	4,01	1484706
Position of previous notification	n/a	n/a	n/a

7. Notified details of the resulting situation

7.A: Voting rights attached to shares

ISIN code	absolute direct (Sec 130 BörseG 2018)	absolute indirect (Sec 133 BörseG 2018)	in % direct (Sec 130 BörseG 2018)	in % indirect (Sec 133 BörseG 2018)
ATMARINOMED6 59596		0	4.01	0.00
Total:		59,596		4.01

7.B.1: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 1 BörseG 2018

type of	Maturity /	Exercise or conversion	Voting Rights	Voting Rights in
instrument	Expiration	period	Absolute	%
		Total:	0	0

7.B.2: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 2 BörseG 2018

type of	Maturity /	Exercise or	Cash or physical	Voting Rights	Voting Rights
instrument	Expiration	conversion period	transaction	Absolute	in %
			Total:	0	0

1. Information in relation to the person subject to the notification obligation

Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.).

1. In case of proxy voting

Date of general meeting: N/A Voting rights after general meeting:

1. Other useful information

die LLB Invest Kapitalanlagegesellschaft hält genannte Aktien als Verwaltungsgesellschaft (KAG) von fünf Investmentfonds. Es gilt hinsichtlich der Zusammenrechnung/Kontrolle die Ausnahme nach § 134 Abs 2 BörseG und § 8 TransV 2018

Emitter:	Marinomed Biotech AG Hovengasse 25 2100 Korneuburg Austria
Contact Person:	Pascal Schmidt, CFO
Phone:	+43 2262 90300
E-Mail:	pascal.schmidt@marinomed.com
Website:	www.marinomed.com
ISIN(s):	ATMARINOMED6 (Share)
Stock Exchange(s):	official trade in Vienna

News transmitted by pressetext. The emitter is responsible for the content.